MANNKIND CORP's ticker is MNKDXXXX and the CUSIP is 56400P201. A total of 140 filers reported holding MANNKIND CORP in Q3 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $42,000 | -52.3% | 66,647 | -53.0% | 0.00% | – |
| Q3 2016 | $88,000 | -46.3% | 141,747 | 0.0% | 0.00% | – |
| Q2 2016 | $164,000 | -28.1% | 141,747 | 0.0% | 0.00% | – |
| Q1 2016 | $228,000 | -5.0% | 141,747 | -14.5% | 0.00% | – |
| Q4 2015 | $240,000 | -50.2% | 165,800 | +10.5% | 0.00% | -100.0% |
| Q3 2015 | $482,000 | -38.7% | 150,100 | +8.7% | 0.00% | 0.0% |
| Q2 2015 | $786,000 | +24.0% | 138,100 | +13.3% | 0.00% | 0.0% |
| Q1 2015 | $634,000 | +3.3% | 121,900 | +3.5% | 0.00% | 0.0% |
| Q4 2014 | $614,000 | +8.3% | 117,800 | +22.8% | 0.00% | 0.0% |
| Q3 2014 | $567,000 | -43.4% | 95,900 | +5.2% | 0.00% | 0.0% |
| Q2 2014 | $1,002,000 | +183.1% | 91,200 | +3.6% | 0.00% | – |
| Q1 2014 | $354,000 | -22.7% | 88,000 | 0.0% | 0.00% | -100.0% |
| Q4 2013 | $458,000 | -4.6% | 88,000 | +4.4% | 0.00% | 0.0% |
| Q3 2013 | $480,000 | -93.1% | 84,300 | -92.1% | 0.00% | -88.9% |
| Q2 2013 | $6,953,000 | – | 1,069,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AYM CAPITAL, LLC | 1,305,000 | $7,713,000 | 5.61% |
| Greywolf Capital Management LP | 6,206,570 | $36,681,000 | 4.08% |
| AYM CAPITAL, LLC | 692,300 | $4,092,000 | 2.98% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 1,412,600 | $8,348,000 | 2.26% |
| B. Riley Wealth Advisors, Inc. | 1,238,880 | $7,322,000 | 1.11% |
| ZEKE LP /PA | 50,000 | $295,000 | 1.06% |
| Old West Investment Management, LLC | 266,566 | $1,575,000 | 0.99% |
| Cohen Capital Management, Inc. | 500,000 | $2,955,000 | 0.79% |
| Tourbillon Capital Partners, L.P. | 3,250,000 | $19,208,000 | 0.70% |
| Adamant Biomedical Investments AG | 300,000 | $1,773,000 | 0.44% |